66 related articles for article (PubMed ID: 9542773)
1. Downmodulation of HLA class I expression by dexamethasone in MCF-7 cell line.
Rodríguez F; Redondo M; Hortas-Nieto ML; Téllez-Santana T; Pérez-Valero V; Ruiz-Cabello F
Rev Esp Fisiol; 1997 Dec; 53(4):355-60. PubMed ID: 9542773
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone induces altered binding of regulatory factors to HLA class I enhancer sequence in MCF-7 breast tumour cell line.
Rodriguez F; Redondo M; Ruiz-Cabello F
Cancer Immunol Immunother; 1998 Jun; 46(4):194-200. PubMed ID: 9671142
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid hormones reduce the expression of major histocompatibility class I antigens on human epithelial cells.
Von Knebel Doeberitz M; Koch S; Drzonek H; Zur Hausen H
Eur J Immunol; 1990 Jan; 20(1):35-40. PubMed ID: 2307177
[TBL] [Abstract][Full Text] [Related]
4. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the expression of major histocompatibility complex class I genes in human colorectal cancer.
Soong TW; Hui KM
Cancer Detect Prev; 1991; 15(3):231-9. PubMed ID: 1905582
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the major histocompatibility complex class I mRNA expression by bile acids in cultured human hepatoma cells.
Hirano F; Tanaka H; Makino Y; Okamoto K; Inaba M; Miura T; Makino I
Biochem Biophys Res Commun; 1995 Mar; 208(3):935-42. PubMed ID: 7702623
[TBL] [Abstract][Full Text] [Related]
7. Expression of major histocompatibility complex antigens in squamous cell carcinomas of the head and neck: effects of interferon gene transfer.
Arosarena OA; Baranwal S; Strome S; Wolf GT; Krauss JC; Bradford CR; Carey TE
Otolaryngol Head Neck Surg; 1999 May; 120(5):665-71. PubMed ID: 10229590
[TBL] [Abstract][Full Text] [Related]
8. MHC class I down-regulation: tumour escape from immune surveillance? (review).
Bubeník J
Int J Oncol; 2004 Aug; 25(2):487-91. PubMed ID: 15254748
[TBL] [Abstract][Full Text] [Related]
9. Modulation of MHC gene expression in human breast carcinoma cells by hormones.
Teh M; Hui KM
J Immunogenet; 1989; 16(4-5):397-405. PubMed ID: 2639911
[TBL] [Abstract][Full Text] [Related]
10. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
[TBL] [Abstract][Full Text] [Related]
12. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
[TBL] [Abstract][Full Text] [Related]
13. MHC expression in a human adult stem cell line and its down-regulation by hCMV US gene transfection.
Kim JY; Kim D; Choi I; Yang JS; Lee DS; Lee JR; Kang K; Kim S; Hwang WS; Lee JS; Ahn C
Int J Biochem Cell Biol; 2005 Jan; 37(1):69-78. PubMed ID: 15381151
[TBL] [Abstract][Full Text] [Related]
14. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
Indrová M; Bieblová J; Jandlová T; Vonka V; Pajtasz-Piasecka E; Reinis M
Int J Oncol; 2006 Jan; 28(1):253-9. PubMed ID: 16328003
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of growth of subcutaneous xenografts and metastasis of human breast carcinoma by swainsonine: modulation of tumor cell HLA class I antigens and host immune effector mechanisms.
Mohla S; White S; Grzegorzewski K; Nielsen D; Dunston G; Dickson L; Cha JK; Asseffa A; Olden K
Anticancer Res; 1990; 10(6):1515-22. PubMed ID: 2126682
[TBL] [Abstract][Full Text] [Related]
17. Selectively down-regulated expression of major histocompatibility complex class I alleles in human solid tumors.
Végh Z; Wang P; Vánky F; Klein E
Cancer Res; 1993 May; 53(10 Suppl):2416-20. PubMed ID: 8485728
[TBL] [Abstract][Full Text] [Related]
18. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
[TBL] [Abstract][Full Text] [Related]
19. The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.
Algarra I; García-Lora A; Cabrera T; Ruiz-Cabello F; Garrido F
Cancer Immunol Immunother; 2004 Oct; 53(10):904-10. PubMed ID: 15069585
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Tat mutants in the cysteine-rich region downregulate HLA class II expression in T lymphocytic and macrophage cell lines.
Tosi G; De Lerma Barbaro A; D'Agostino A; Valle MT; Megiovanni AM; Manca F; Caputo A; Barbanti-Brodano G; Accolla RS
Eur J Immunol; 2000 Jan; 30(1):19-28. PubMed ID: 10602023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
